RPRX - Royalty Pharma plc
IEX Last Trade
25.49
0 0%
Share volume: 44,531
Last Updated: Fri 27 Dec 2024 08:30:25 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$25.49
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-04 | 2022-11-08 | 2023-02-15 | 2023-05-09 | 2023-08-08 | 2023-11-08 | 2024-02-15 | 2024-05-09 | |
| Total revenue | 535.955 M | 573.463 M | 565.748 M | 683.971 M | 538.202 M | 536.313 M | 596.068 M | 567.978 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 535.955 M | 573.463 M | 565.748 M | 683.971 M | 538.202 M | 536.313 M | 596.068 M | 567.978 M | |
| 7.00% | -1.35% | 20.90% | -21.31% | -0.35% | 11.14% | -4.71% | |||
| Operating expenses | 52.449 M | 76.192 M | 123.728 M | 86.195 M | 48.134 M | 107.734 M | 59.685 M | 58.152 M | |
| Selling general and admin | 51.843 M | 50.692 M | 73.228 M | 85.695 M | 47.634 M | 57.234 M | 59.185 M | 57.652 M | |
| Research and development | 606.000 K | 25.500 M | 50.500 M | 500.000 K | 500.000 K | 50.500 M | 500.000 K | 500.000 K | |
| Total expenses | 52.449 M | 76.192 M | 1.037 B | 86.195 M | 48.904 M | 112.956 M | 614.349 M | 72.301 M | |
| 45.27% | 1,260.96% | -91.69% | -43.26% | 130.97% | 443.88% | -88.23% | |||
| Operating income | 483.506 M | 497.271 M | -471.197 M | 597.776 M | 489.298 M | 423.357 M | -18.281 M | 495.677 M | |
| Ebit | 378.529 M | 188.959 M | 126.316 M | 513.578 M | 248.070 M | 146.220 M | 613.164 M | -87.923 M | |
| Pretax income | 491.597 M | 220.414 M | -610.030 M | 509.089 M | 351.336 M | 122.077 M | 717.586 M | -4.273 M | |
| -55.16% | -376.77% | -183.45% | -30.99% | -65.25% | 487.81% | -100.60% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 304.504 M | 142.651 M | -456.084 M | 340.755 M | 227.625 M | 72.114 M | 494.340 M | 4.778 M | |
| -53.15% | -419.72% | 174.71% | -33.20% | -68.32% | 585.50% | -99.03% | |||
| Net income | 304.504 M | 142.651 M | -456.084 M | 340.755 M | 227.625 M | 72.114 M | 494.340 M | 4.778 M | |
| -53.15% | -419.72% | 174.71% | -33.20% | -68.32% | 585.50% | -99.03% |